Company profile: Biovail
1.1 - Company Overview
Company description
- Provider of pharmaceuticals as a Canadian pharmaceutical company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biovail
Lanthiopharma
HQ: The Netherlands
Website
- Description: Provider of drug discovery focused on therapeutic lantipeptide drugs for serious diseases, applying proprietary lanthionine-peptide technology (LanthioPepTM) to generate novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lanthiopharma company profile →
Anji Pharma
HQ: United States
Website
- Description: Provider of therapeutics targeting high-value, human genetics-validated targets, including ANJ900, a gut-targeted formulation of metformin for type 2 diabetes patients with advanced chronic kidney disease to lower glucose with reduced systemic exposure, and ANJ908 (Pradigastat), a DGAT1 inhibitor for chronic idiopathic constipation to increase bowel movement frequency and soften stool.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anji Pharma company profile →
Axys Pharmaceuticals
HQ: United States
Website
- Description: Provider of discovery, design, and development services for therapeutic small molecules addressing significant markets with major unmet medical needs; collaborates with large pharmaceutical companies to discover therapeutics for chronic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axys Pharmaceuticals company profile →
Redx Pharma
HQ: United Kingdom
Website
- Description: Provider of drug discovery and development advancing clinical-stage assets Zelasudil (ROCK2 inhibitor for idiopathic pulmonary fibrosis and fibrotic diseases), Zamaporvint (Porcupine inhibitor for Wnt-ligand driven cancer), RXC008 (GI-targeted pan-ROCK for fibrostenotic Crohn's), and a Drug Discovery Engine supporting programs in fibrosis and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Redx Pharma company profile →
Roivant
HQ: United States
Website
- Description: Provider of biopharmaceutical medicines and healthcare technologies, developing VTAMA (tapinarof) cream for plaque psoriasis and atopic dermatitis in adults and children 2+, Brepocitinib (TYK2/JAK1) for dermatomyositis and non-infectious uveitis, IMVT-1402 (FcRn inhibitor) for autoimmune diseases including Graves' disease, Namilumab for sarcoidosis, and Mosliciguat for pulmonary hypertension associated with interstitial lung disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Roivant company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biovail
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biovail
2.2 - Growth funds investing in similar companies to Biovail
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biovail
4.2 - Public trading comparable groups for Biovail
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →